258 related articles for article (PubMed ID: 21533227)
41. GPAT3 deficiency alleviates insulin resistance and hepatic steatosis in a mouse model of severe congenital generalized lipodystrophy.
Gao M; Liu L; Wang X; Mak HY; Liu G; Yang H
Hum Mol Genet; 2020 Feb; 29(3):432-443. PubMed ID: 31873720
[TBL] [Abstract][Full Text] [Related]
42. Seipin differentially regulates lipogenesis and adipogenesis through a conserved core sequence and an evolutionarily acquired C-terminus.
Yang W; Thein S; Guo X; Xu F; Venkatesh B; Sugii S; Radda GK; Han W
Biochem J; 2013 May; 452(1):37-44. PubMed ID: 23458123
[TBL] [Abstract][Full Text] [Related]
43. Mice deficient in ER protein seipin have reduced adrenal cholesteryl ester lipid droplet formation and utilization.
Shen WJ; Cortez Y; Singh A; Chen W; Azhar S; Kraemer FB
J Lipid Res; 2022 Dec; 63(12):100309. PubMed ID: 36332685
[TBL] [Abstract][Full Text] [Related]
44. Novel metabolic disorders in skeletal muscle of Lipodystrophic Bscl2/Seipin deficient mice.
Xu W; Zhou H; Xuan H; Saha P; Wang G; Chen W
Mol Cell Endocrinol; 2019 Feb; 482():1-10. PubMed ID: 30521848
[TBL] [Abstract][Full Text] [Related]
45. Changes in redox and endoplasmic reticulum homeostasis are related to congenital generalized lipodystrophy type 2.
Craveiro Sarmento AS; Gomes Lima J; de Souza Timoteo AR; Galvão Ururahy MA; Antunes de Araújo A; Carvalho Vasconcelos R; Cândido Dantas VK; Fassarella Agnez-Lima L; Araújo de Melo Campos JT
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Apr; 1865(4):158610. PubMed ID: 31917334
[TBL] [Abstract][Full Text] [Related]
46. Genotype-phenotype correlations of Berardinelli-Seip congenital lipodystrophy and novel candidate genes prediction.
Ren M; Shi J; Jia J; Guo Y; Ni X; Shi T
Orphanet J Rare Dis; 2020 Apr; 15(1):108. PubMed ID: 32349771
[TBL] [Abstract][Full Text] [Related]
47. Seipin: harvesting fat and keeping adipocytes healthy.
Rao MJ; Goodman JM
Trends Cell Biol; 2021 Nov; 31(11):912-923. PubMed ID: 34215489
[TBL] [Abstract][Full Text] [Related]
48. Berardinelli-seip congenital lipodystrophy 2/seipin is a cell-autonomous regulator of lipolysis essential for adipocyte differentiation.
Chen W; Chang B; Saha P; Hartig SM; Li L; Reddy VT; Yang Y; Yechoor V; Mancini MA; Chan L
Mol Cell Biol; 2012 Mar; 32(6):1099-111. PubMed ID: 22269949
[TBL] [Abstract][Full Text] [Related]
49. Alleviation of seipinopathy-related ER stress by triglyceride storage.
Hölttä-Vuori M; Salo VT; Ohsaki Y; Suster ML; Ikonen E
Hum Mol Genet; 2013 Mar; 22(6):1157-66. PubMed ID: 23250914
[TBL] [Abstract][Full Text] [Related]
50. Analysis of naturally occurring mutations in the human lipodystrophy protein seipin reveals multiple potential pathogenic mechanisms.
Sim MF; Talukder MM; Dennis RJ; O'Rahilly S; Edwardson JM; Rochford JJ
Diabetologia; 2013 Nov; 56(11):2498-506. PubMed ID: 23989774
[TBL] [Abstract][Full Text] [Related]
51. Exercise Increases Bone in SEIPIN Deficient Lipodystrophy, Despite Low Marrow Adiposity.
McGrath C; Little-Letsinger SE; Sankaran JS; Sen B; Xie Z; Styner MA; Zong X; Chen W; Rubin J; Klett EL; Coleman RA; Styner M
Front Endocrinol (Lausanne); 2021; 12():782194. PubMed ID: 35145475
[TBL] [Abstract][Full Text] [Related]
52. Progressive Myoclonus Epilepsy in Congenital Generalized Lipodystrophy type 2: Report of 3 cases and literature review.
Opri R; Fabrizi GM; Cantalupo G; Ferrarini M; Simonati A; Dalla Bernardina B; Darra F
Seizure; 2016 Nov; 42():1-6. PubMed ID: 27632409
[TBL] [Abstract][Full Text] [Related]
53. Adipose specific disruption of seipin causes early-onset generalised lipodystrophy and altered fuel utilisation without severe metabolic disease.
Mcilroy GD; Suchacki K; Roelofs AJ; Yang W; Fu Y; Bai B; Wallace RJ; De Bari C; Cawthorn WP; Han W; Delibegović M; Rochford JJ
Mol Metab; 2018 Apr; 10():55-65. PubMed ID: 29459250
[TBL] [Abstract][Full Text] [Related]
54. Reep1 null mice reveal a converging role for hereditary spastic paraplegia proteins in lipid droplet regulation.
Renvoisé B; Malone B; Falgairolle M; Munasinghe J; Stadler J; Sibilla C; Park SH; Blackstone C
Hum Mol Genet; 2016 Dec; 25(23):5111-5125. PubMed ID: 27638887
[TBL] [Abstract][Full Text] [Related]
55. Gene and phenotype analysis of congenital generalized lipodystrophy in Japanese: a novel homozygous nonsense mutation in seipin gene.
Ebihara K; Kusakabe T; Masuzaki H; Kobayashi N; Tanaka T; Chusho H; Miyanaga F; Miyazawa T; Hayashi T; Hosoda K; Ogawa Y; Nakao K
J Clin Endocrinol Metab; 2004 May; 89(5):2360-4. PubMed ID: 15126564
[TBL] [Abstract][Full Text] [Related]
56. Identification of Genetic Suppressors for a Berardinelli-Seip Congenital Generalized Lipodystrophy Type 2 (BSCL2) Pathogenic Variant in
Bai X; Smith HE; Golden A
bioRxiv; 2023 Sep; ():. PubMed ID: 37790539
[TBL] [Abstract][Full Text] [Related]
57. Human SEIPIN Binds Anionic Phospholipids.
Yan R; Qian H; Lukmantara I; Gao M; Du X; Yan N; Yang H
Dev Cell; 2018 Oct; 47(2):248-256.e4. PubMed ID: 30293840
[TBL] [Abstract][Full Text] [Related]
58. Analyzing the functions and structure of the human lipodystrophy protein seipin.
Sim MF; Talukder MU; Dennis RJ; Edwardson JM; Rochford JJ
Methods Enzymol; 2014; 537():161-75. PubMed ID: 24480346
[TBL] [Abstract][Full Text] [Related]
59. Novel mutations of the BSCL2 and AGPAT2 genes in 10 families with Berardinelli-Seip congenital generalized lipodystrophy syndrome.
Miranda DM; Wajchenberg BL; Calsolari MR; Aguiar MJ; Silva JM; Ribeiro MG; Fonseca C; Amaral D; Boson WL; Resende BA; De Marco L
Clin Endocrinol (Oxf); 2009 Oct; 71(4):512-7. PubMed ID: 19226263
[TBL] [Abstract][Full Text] [Related]
60. Seipin is involved in the regulation of phosphatidic acid metabolism at a subdomain of the nuclear envelope in yeast.
Wolinski H; Hofbauer HF; Hellauer K; Cristobal-Sarramian A; Kolb D; Radulovic M; Knittelfelder OL; Rechberger GN; Kohlwein SD
Biochim Biophys Acta; 2015 Nov; 1851(11):1450-64. PubMed ID: 26275961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
